Cargando…
Techniques for Detection of Clinical Used Heparins
Heparins and sulfated polysaccharides have been recognized as effective clinical anticoagulants for several decades. Heparins exhibit heterogeneity depending on the sources. Meanwhile, the adverse effect in the clinical uses and the adulteration of oversulfated chondroitin sulfate (OSCS) in heparins...
Autores principales: | Li, Binjie, Zhao, Huimin, Yu, Mingjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121598/ https://www.ncbi.nlm.nih.gov/pubmed/34040644 http://dx.doi.org/10.1155/2021/5543460 |
Ejemplares similares
-
Elucidating the Binding Mode between Heparin and Inflammatory Cytokines by Molecular Modeling
por: Yu, Mingjia, et al.
Publicado: (2021) -
Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening
por: Li, Binjie, et al.
Publicado: (2023) -
Update on the clinical use of the low-molecular-weight heparin, parnaparin
por: Camporese, Giuseppe, et al.
Publicado: (2009) -
Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
por: Locke, Charles FS, et al.
Publicado: (2005) -
Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
por: Tardy, Brigitte, et al.
Publicado: (2020)